Number of events and deaths for 1-year follow-up in the Danish population (all patients, patients on OAC, low-risk patients), GARFIELD-AF Global and GARFIELD-AF Scandinavia
| Danish AF cohort (n=90 693) | Patients treated with OAC (n=51 180) | Low-risk patients (n=20 673) | GARFIELD Scandinavia (n=2396) | GARFIELD-AF Global (n=52 080) | |
| Ischaemic Stroke/SE | 2094 | 994 | 139 | 24 | 599 |
| Major bleeding/haemorrhagic stroke | 2642 | 1492 | 242 | 28* | 341† |
| Deaths | 10 915 | 4521 | 623 | 88 | 2459 |
Low-risk patients were defined as CHA2DS2-VASc score (≤2 for women, 0–1 for men and >2 for women and >1 for men).
*Of those treated with OAC (n=1631)
†Of those treated with OAC (n=31 712)
AF, atrial fibrillation; GARFIELD-AF, Global Anticoagulant Registry in the FIELD-Atrial Fibrillation; OAC, oral anticoagulation; SE, systemic embolism.